Related Experiment Videos
Myocardial preservation in heart transplantation
1Department of Cardiothoracic Surgery, Singapore General Hospital.
Insights
Maximizing donor heart availability requires preserving organ function during brain death. Research into cardioplegia and preservation fluids can minimize cardiac ischemia and reperfusion injury, improving long-term transplant survival.
Area of Science:
- Cardiology
- Transplantation Medicine
- Organ Preservation
Background:
- Cardiac transplantation success is high, but donor organ shortage persists.
- Brain death leads to pathophysiological changes impacting myocardial function.
- Minimizing graft failure requires optimizing donor organ quality and availability.
Purpose of the Study:
- To investigate strategies for myocardial preservation in potential organ donors.
- To explore methods for protecting the heart from brain death-related injury.
- To enhance donor availability and improve long-term cardiac transplant outcomes.
Main Methods:
- Reviewing current donor procurement and preservation techniques.
- Investigating the role of cardioplegia, additives, and preservation fluids.
- Analyzing evidence for improved long-term survival through tissue matching.
Main Results:
- Current techniques offer low non-rejection graft failure rates.
- Strategies for myocardial preservation are crucial for maximizing donor availability.
- Tissue matching shows potential for improving long-term survival.
Conclusions:
- Donor organ preservation is key to addressing donor shortages in cardiac transplantation.
- Further research on cardioplegia and preservation fluids is needed to mitigate ischemia-reperfusion injury.
- Extending safe ischemic time is essential for effective tissue matching and organ sharing.
Abstract:
The current techniques of donor procurement and transplantation provide a very low incidence "of non rejection graft failure", following cardiac transplantation. Attention needs to be paid to the preservation of organ function in the potential donor, in order to maximise the donor availability in an environment of perpetual donor shortage. The strategies aimed at myocardial preservation in the donor will be methods of protection from the pathophysiological changes associated with onset of cerebral injury and brain death. The role of various types of cardioplegia, additives and preservation fluids need to be investigated to minimise the effects of cardiac ischaemia and reperfusion injury. There is evidence to suggest the improvement in long term survival with tissue matching in cardiac transplantation. This will need methods of prolonging safe ischaemic time for the donor heart so that tissue matching and organ sharing can be carried out.